DiagnosTear Technologies Inc. (CSE: DTR) (FSE: X8F) ("DiagnosTear" or the "Company"), a fast-growing innovator in point-of-care ocular diagnostics, today announced highly encouraging interim results ...
Background While female sex has historically been associated with worse outcomes following surgical aortic valve replacement, ...